Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design - Wikidata - awgldk - TriplyDB

Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design

Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design

http://www.wikidata.org/entity/Q35055214

about

Analysis of time to event outcomes in randomized controlled trials by generalized additive models Heart disease and stroke statistics--2014 update: a report from the American Heart Association Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons Low awareness of stroke guidelines and preference for Chinese herbs in community physicians: a national survey in China.Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.Long-term outcome of vertebral artery origin stenosis in patients with acute ischemic stroke.Center for stroke disparities solutions community- based care transition interventions: study protocol of a randomized controlled trial.Management of vascular risk factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).One-year follow-up in patients with brainstem infarction due to large-artery atherothrombosis.Changes in stroke epidemiology, prevention, and treatment.A Retrospective Cohort Study Comparing Stroke Recurrence Rate in Ischemic Stroke Patients With and Without Acupuncture Treatment Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study Stroke Disparities: Large Global Problem That Must Be Addressed.The 2012 Feinberg Lecture: treatment swift and treatment sure.Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke.Addressing Stroke Risk Factors in Black and White Americans: Findings from the National Health and Nutrition Examination Survey, 2009-2010 Trends in Incident and Recurrent Rates of First-Ever Ischemic Stroke in Taiwan between 2000 and 2011.A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.Changes in pre-hospital management of vascular risk factors among patients admitted due to recurrent stroke in Poland from 1995 to 2013.Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack.Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.Renin-Angiotensin system modulators modestly reduce vascular risk in persons with prior stroke.Low ankle-brachial index predicts new vascular events and functional outcome after 1 year in patients with non-cardioembolic stroke: our experience and review.Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.Blood pressure control versus atrial fibrillation management in stroke prevention.Dual antiplatelet therapy in acute ischemic stroke.Shifting Trend of Transient Ischemic Attack Admission and Prognosis in Canada.Practice Patterns for Acute Ischemic Stroke Workup: A Longitudinal Population-Based Study.When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy.Trends in risk of recurrence after the first ischemic stroke in adults younger than 55 years of age in Sweden.High-resolution vessel wall MRI for the evaluation of intracranial atherosclerotic disease.Clinical relevance of abnormal neuroimaging findings and long-term risk of stroke recurrence.Transcatheter closure of patent foramen ovale for secondary prevention of ischemic stroke: Quantitative synthesis of pooled randomized trial data.Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke.Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke.Why do transient ischemic attack patients have higher early stroke recurrence risk than those with ischemic stroke? Influence of patient behavior and other risk factors in the North Dublin Population Stroke Study.A positive association between stroke risk and sarcopenia in men aged ≥ 50 years, but not women: results from the Korean National Health and Nutrition Examination Survey 2008-2010.

P2860

Q27309297-E2AB1F7A-45FD-4CD1-885A-07AD0B24741E Q29547691-3CE05B1A-3669-4425-86B8-1B2B0FD80201 Q30238784-48F40E32-27A0-4383-BD78-6FB9CEDCB6D0 Q30789930-E03E14BE-2C78-4B92-A205-D43311AD6A21 Q33911647-066E87B2-41E3-40F3-BE5A-A794069BCA81 Q34357837-1BE92F45-C64E-4F35-BB73-AFFC55A7E8D9 Q35019512-9E015E2D-651C-4E16-AFB8-67242D0D686F Q35038384-F0D8C217-E4DC-4200-9A92-13B54E04E92A Q35066058-06CF530C-A815-4FE0-B59D-48A5E6174CEA Q35114958-DF5CCC7E-5924-4D41-9F4C-EADFAE516594 Q35121446-2CB7CE75-0ED1-490B-BF84-2F5A929F08F8 Q35850235-E9BBC886-29D7-4F9C-96D9-DC55AA0B2E1B Q36195842-052054CF-9D9B-4063-AD44-3A19EB74359C Q36208099-66B6DC51-008D-453A-B87D-DB3225A652FF Q36319569-D694CF90-5803-4716-8DAB-42EE07DD7ACD Q36488015-A2E84111-2864-4956-B473-DCA7003977C4 Q36521257-103244EA-7F43-4214-88BD-ED9BC9BBCAFB Q36537503-BDDA1FFC-8A06-47E1-B0D8-DFE7A511181D Q36561322-AEAB72EC-5AF4-4CAC-9D48-EEDFC06CFF9A Q36685755-958EFB4C-790D-4530-BDAD-219B6CA4087D Q36832485-9D620281-A310-49E9-AE9B-1694DEAAC7AD Q37100539-1041F87E-ED72-4F96-B804-110993C1E556 Q37341721-974FA1BE-12D8-4D29-8578-093486CE8399 Q37691484-DB98C105-2D64-4FC9-8309-E34658B763D4 Q37952611-5BC1F749-B8BB-4943-A509-DAA0DB442FB7 Q38134136-C74A9E60-DCBD-4F41-BB03-3E03223E3889 Q38169038-F4A2ED8B-04D2-4FB7-8403-098D351F9979 Q38429854-D69B7BFD-0E1A-4F5A-9A50-93B31943B6DF Q38492202-7EBCE5EA-1A23-48FB-88E6-B5933CD07D63 Q38648099-78EF5836-56D6-4998-A466-555776C95877 Q38667369-FA1F723E-C4E5-4B41-B0D5-943C64BFC443 Q38904060-E81692D8-5BB1-4CBF-8421-1B2A822FDD25 Q40980109-26543E41-91DE-4445-8513-D32905588C08 Q47932405-465CB788-DF7F-4782-BFE6-EDA1CF0254BA Q48142983-D61090FD-7C46-4F90-97B0-D646DD802D53 Q48247951-34B017EA-1234-4BC2-B9E6-2F6924D533DC Q48409860-F339D1BE-C893-4890-98DA-1B6428988915 Q48596830-DECDEC77-0C71-4113-B197-E62219DB5F23 Q51784486-686BC31A-BAC7-45A0-9080-44DED585FABA Q53251288-91C4799F-F36D-40B0-865F-512AA1E61266

P2860

Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design

http://www.wikidata.org/entity/Q35055214

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Declining stroke and vascular ...... ences for current trial design

@ast

Declining stroke and vascular ...... ences for current trial design

@en

type

label

Declining stroke and vascular ...... ences for current trial design

@ast

Declining stroke and vascular ...... ences for current trial design

@en

prefLabel

Declining stroke and vascular ...... ences for current trial design

@ast

Declining stroke and vascular ...... ences for current trial design

@en

P1433

Q35055214-25C40554-E53E-4BE8-BAD8-A4D47ED59E3F

P1476

Q35055214-10FB9B00-24B9-412D-8794-65BD9DA42DE9

P2093

Q35055214-79712688-4EAA-43AD-AC70-C5DA7BA5D144

Q35055214-8406CD47-0D1F-434F-AB03-95E94CAFF31A

Q35055214-8A110154-01EE-4D14-AA5E-379B5F9C649A

Q35055214-8DBA6A10-0C70-4D27-B6AE-88CC433FDA11

Q35055214-D6A4B013-4174-46D8-8204-D84BBCFCEBCE

P2860

Q35055214-108A22F1-1495-4A41-8AFE-35EA4262F1A3

Q35055214-1BF857D7-A241-4716-8CE9-838E5743E03F

Q35055214-1EF9FA31-472C-453F-9B1F-2A0DBAB71130

Q35055214-388821D9-4A3F-4094-B601-1EE19B3CF40B

Q35055214-3F85696E-2594-4843-A28D-EB9EF96FE015

Q35055214-72BF0755-0D54-4541-8B43-D0DDD5FCB123

Q35055214-8901EFF2-B754-4568-982E-0A7659B37FBA

Q35055214-96000AFB-DE49-4408-BC9C-FCA528A7CC86

Q35055214-B2D73500-CC37-4B1B-AC8A-50B9D3A2550F

Q35055214-D419B8D3-872C-4636-A4B5-CFD254F26A74

P304

Q35055214-197321C1-6F64-4486-8FDD-6666A834995D

P31

Q35055214-A89FBCC0-2760-4EED-8D14-DF4580043964

P356

Q35055214-B1889124-545F-42F2-867E-8F58F6723E98

P407

Q35055214-1D619F8D-3F6B-4559-8B07-6258E577AC94

P433

Q35055214-72057B14-2076-450F-9669-57F1D9EC9237

P478

Q35055214-582EE39D-20EC-4339-BAEB-318285A0CC67

P577

Q35055214-80D7F023-487F-4748-9807-99A0FF3A1C83

P5875

Q35055214-BFE76B8E-437C-4C80-8287-9C174ABADBB2

P698

Q35055214-921B35CE-E803-46C3-B56B-278AC446C212

P932

Q35055214-2C1220C2-8B56-4EEA-9154-E77183498358

P356

CIRCULATIONAHA.109.934786

P1433

P1476

Declining stroke and vascular ...... ences for current trial design

@en

P2093

Jeffrey L Saver

http://www.w3.org/2001/XMLSchema#string

Juneyoung Lee

http://www.w3.org/2001/XMLSchema#string

Keun-Sik Hong

http://www.w3.org/2001/XMLSchema#string

Meng Lee

http://www.w3.org/2001/XMLSchema#string

Sharon Yegiaian

http://www.w3.org/2001/XMLSchema#string

P2860

Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.

Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.

Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis.

Is there a decline in the vascular event rate after transient ischemic attack or stroke in antiplatelet trials?

Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years.

Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack.

Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort.

P304

2111-2119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.934786

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51093018

http://www.w3.org/2001/XMLSchema#string

P698

21536995

http://www.w3.org/2001/XMLSchema#string

P932

3118516

http://www.w3.org/2001/XMLSchema#string